Coronavirus Update: New Clinical Trials Network Could Help Pick Vaccine, Antibody Winners Faster

Launched By Operation Warp Speed

Plus: the World Health Organization has commissioned an independent panel to look at pandemic responses, while the emergence of an unknown pneumonia in Kazakstan is causing concern.  

WHO
WHO director Dr Tedros Adhanom Ghebreyesus has asked an independent commission to consider global responses to the pandemic.

A new US and international clinical trials network has been launched, with the goal of accelerating recruitment for large-scale trials of vaccine candidates and investigational monoclonal antibodies against COVID-19.

Launched under the auspices of the US government's Operation Warp Speed and the National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID), the network is meant to address the fragmented nature of COVID-19

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from COVID-19

More from Scrip

Novo Nordisk Looks To Septerna For Oral Obesity Options

 

Deal Snapshot: The Danish drugmaker is partnering with GPCR drug discovery expert Septerna to develop multiple small molecules for cardiometabolic targets.

AbbVie On MFN: ‘We Have To Take It Seriously’

 

AbbVie chief commercial officer Jeffrey Stewart called Trump’s drug pricing plan a “disruption” but said ultimately the delta between US and EU drug prices may not be as high as some expect.

Industry Leaders Grapple With Trump’s MFN Pricing Plan

 

At the Bank of America health care conference, pharma leaders speculated on what Trump’s executive order on drug pricing could mean for US and European drug prices.